ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,319.20
      2.45%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.10
      -0.30%
      Bitcoin
      62,833.20
      -0.19%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Palatin Technologies Inc New (PTN) Quote

      Palatin Technologies Inc New

      Palatin Technologies Inc New (PTN)

      Patronus Resources Ltd
      Palatin Technologies Inc
      Proton Capital Corp
      1.29
      -0.07
      (-5.15%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      1.309
      0.019
      (1.47%)
      After Hours: 7:09PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.309
      Bid
      -
      Ask
      -
      Volume
      337,353
      1.24 Day's Range 1.42
      1.29 52 Week Range 5.65
      Market Cap
      25.355M
      Previous Close
      1.36
      Open
      1.40
      Last Trade
      1
      @
      1.3
      Last Trade Time
      Financial Volume
      $ 457,312
      VWAP
      1.3556
      Average Volume (3m)
      127,290
      Shares Outstanding
      19,370,000
      Dividend Yield
      -
      PE Ratio
      -0.91
      Earnings Per Share (EPS)
      -1.42
      Revenue
      5.88M
      Net Profit
      -27.54M

      About Palatin Technologies Inc New

      Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me... Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      palatin.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Palatin Technologies Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker PTN. The last closing price for Palatin Technologies was $1.36. Over the last year, Palatin Technologies shares have traded in a share price range of $ 1.29 to $ 5.65.

      Palatin Technologies currently has 19,370,000 shares outstanding. The market capitalization of Palatin Technologies is $26.34 million. Palatin Technologies has a price to earnings ratio (PE ratio) of -0.91.

      Ask ADVFN Intelligence (AI)

      PTN Latest News

      More News

      Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones

      Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones PR Newswire CRANBURY, N.J., Sept. 9, 2024 Dry Eye Disease (DED): PL9643MELODY-2 & MELODY-3 Phase...

      September 09 2024
      PR Newswire (US)

      Form 8-K - Current report

      September 06 2024
      Edgar (US Regulatory)

      FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)

      FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED) PR Newswire CRANBURY, N.J., Aug. 28, 2024 FDA & Palatin agree on clear...

      August 28 2024
      PR Newswire (US)

      First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity

      First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity PR Newswire CRANBURY, N.J., Aug. 22, 2024 Complete...

      August 22 2024
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 02 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 31 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 31 2024
      Edgar (US Regulatory)

      Form S-1 - General form for registration of securities under the Securities Act of 1933

      July 25 2024
      Edgar (US Regulatory)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

      July 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 16 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.151-10.34246575341.461.48991.291276171.40737962CS
      4-0.111-7.816901408451.421.721.291455131.50026511CS
      12-0.521-28.46994535521.831.981.291272901.54355104CS
      26-0.271-17.15189873421.582.881.292524951.88366088CS
      52-0.531-28.85869565221.845.651.293037582.51053178CS
      1560.848183.9479392620.4618.60.181111038630.82820235CS
      2600.33934.94845360820.978.60.181115945260.75456276CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SGNSigning Day Sports Inc
      $ 0.5169
      (297.92%)
      		536.16M
      ATCHAtlasClear Holdings Inc
      $ 0.1755
      (23.24%)
      		1.18M
      RYDERyde Group Ltd
      $ 1.379
      (22.04%)
      		8.47M
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 30.16
      (18.20%)
      		1.23M
      ETHTProshares Ultra Ether ETF
      $ 13.59
      (13.16%)
      		247.76k
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 20.13
      (-17.68%)
      		32.16k
      MMAAlta Global Group Limited
      $ 2.74
      (-16.97%)
      		14.2k
      HCWCHealthy Choice Wellness Corp
      $ 2.9701
      (-15.14%)
      		240.03k
      EFSH1847 Holdings LLC
      $ 1.715
      (-14.25%)
      		184.5k
      ETHDProshares Ultrashort Ether ETF
      $ 64.22
      (-12.91%)
      		34.6k
      SGNSigning Day Sports Inc
      $ 0.5169
      (297.92%)
      		536.16M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 35.12
      (12.78%)
      		119.63M
      SOXSDirexion Daily Semiconductor Bear 3X Shares New
      $ 21.74
      (-12.76%)
      		89.32M
      SPYSPDR S&P 500
      $ 570.98
      (1.71%)
      		70.83M
      SPXSDirexion Daily S&P 500 Bear 3X Shares New
      $ 6.86
      (-5.12%)
      		55.11M

      PTN Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      PTN under $2
      👍️0
      zeusgodmd zeusgodmd 4 weeks ago
      I got enough for the ride
      👍️0
      zeusgodmd zeusgodmd 4 weeks ago
      Time to load up
      👍️0
      Monksdream Monksdream 2 months ago
      PTN under $2
      👍️0
      Monksdream Monksdream 2 months ago
      PTN under $2
      👍️0
      mike1986 mike1986 5 months ago
      You may just get your wish. This stock has been making promises for years and now expects everyone to wait until 2025 for any hope of marketing its dry eye ointment, while looking for a partner to do the heavy lifting. Ahhhhhhh..........
      👍️0
      Stockexpertpro Stockexpertpro 5 months ago
      PTN Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024

      https://finance.yahoo.com/news/palatin-announces-phase-3-pl9643-113000533.html
      👍️0
      zeusgodmd zeusgodmd 6 months ago
      Waiting for 1.25
      👍️0
      Monksdream Monksdream 6 months ago
      PTN under $2
      👍️0
      mte1955 mte1955 7 months ago
      Well just great. Pump it the few days before the announcement and sell it on the news.
      👍️0
      mike1986 mike1986 7 months ago
      I love the way these low cap stocks move up and down on no news.
      👍️0
      mike1986 mike1986 7 months ago
      On the move with high volume. Hope something announced soon.
      👍️ 1
      mte1955 mte1955 7 months ago
      So I guess people are disappointed with the latest report. Nothing new but nothing detrimental either.
      👍️0
      zeusgodmd zeusgodmd 8 months ago
      Did not see that coming. Why can’t they what. Til after the news
      👍️0
      zeusgodmd zeusgodmd 8 months ago
      Guess no news this week
      👍️0
      zeusgodmd zeusgodmd 9 months ago
      There are people here that seem to start buying 3 days before a big announcement but everybody is looking at before the end of the year will see
      👍️0
      power11 power11 9 months ago
      ANY SPECIFIC DATE ???
      THANKS
      👍️0
      zeusgodmd zeusgodmd 9 months ago
      News next week
      👍️0
      zeusgodmd zeusgodmd 10 months ago
      Good luck in am. Need a new partner to launch eye sauce. Royalty payments with a down payment. New sex med, new Ibs med why are we at 2$
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      It was going a nice direction why fk it up.
      👍️0
      mike1986 mike1986 11 months ago
      Seems more like unloading today. Buy the rumor, sell the news.
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Highest volume in over a year will take it. Money managers starting the load
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Stepping up the right way
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      It’s only up one buck a lot more money to be made
      👍️0
      johnb214 johnb214 11 months ago
      All time is around 1,670.00. A large Pharma should buy the stock and acquire it versus just paying for one or two of their drugs.
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Nice moves not 8 yet
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Last 3 days tells the story people loading the boat
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Hw investors calling for 75$ I’ve seen that call once by them at it was right on rambus stock
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Not to 8$ yet
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Will take shorts 5 days to cover. Good run
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Stock going to get out of the shitter soon should be 8$
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      They need to start looking for a marketing and sale partnership for eye product and Ibs product
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Good loading day. Good news will come.
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      Maybe falls to floor tomorrow time to buy good luck to sll
      👍️0
      zeusgodmd zeusgodmd 11 months ago
      It time for them to get in bed with a eye company and get some funding and royalty plans with them.
      👍️ 1
      Monksdream Monksdream 12 months ago
      PTN under $2
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Let’s see 2.00
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Will see 220 soon
      👍️0
      mike1986 mike1986 1 year ago
      Buy on the rumor, sell on the news!
      👍️0
      mike1986 mike1986 1 year ago
      Nice move last few day. Congratulations to the faithful!
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Bad new coming I quess
      👍️0
      AJ Freely AJ Freely 1 year ago
      $PTN - Up 8% Pre-Market/ Current Price $2.44
      Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
      ??31% growth over 2Q '23; 165% growth over 3Q '22
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Nice day something up
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Yes there’s only like 11 million shares to this company and maybe 8 million warrants at higher prices. They have 3 good pipeline s of new drugs. First one will shoot it to 30 once nda gets approval. This one should be 8$ already with the low float. It will be bought and taken out buy a big eye company and the ulcerative colitis will be bought or co sold with Merck or another big boy wait and see
      👍️0
      stevenjklein stevenjklein 1 year ago
      PTN Palatin Technologies, Inc.

      Stock Split History (link goes to Seeking Alpha)

      Date Ratio
      Aug. 31, 2022 1:25
      Sep. 27, 2010 1:10
      Sep. 08, 1997 1:4
      Jul. 22, 1996 1:10
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      The board has to get there shares before the company gets sold. Now set the price
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      I think we will see in next year no problem when products go to nda they will be bought buy a big guy or partners with ability to buy Ibs drug also that is where the stock will shoot the gap
      👍️0
      mike1986 mike1986 1 year ago
      Well at $8 I am ahead. $ 20 makes this a home run.
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      They also did a 20 for one stock split to shares trading at 10 cents it will go up fast with good news. Should be 8$ by now
      👍️0
      zeusgodmd zeusgodmd 1 year ago
      Company’s future and products. If they start selling sex drug Europe then profits going up. But there pipeline is in stage 2 and 3 drugs with eye drug will be a good deal with all the old people in the USA. Those drugs are expensive any eye drops. They will partner up with some big company for there sales force and probably get a payment up front and royalties then the Ibs drug comes out of the pipe game on. HW a research company has company valued at 75$ a share.
      👍️0

      Your Recent History

      AMEX
      PTN
      Palatin Technologies
      Delayed Upgrade Clock